Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mona Abaza

Concepts (151)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Otolaryngology
10
2021
84
3.080
Why?
Voice Disorders
8
2017
21
1.710
Why?
Personnel Selection
4
2019
73
1.370
Why?
Internship and Residency
8
2019
1056
1.340
Why?
Laryngoscopy
3
2023
109
0.810
Why?
Larynx
3
2015
54
0.770
Why?
Physicians, Women
1
2021
69
0.700
Why?
Learning
1
2023
381
0.640
Why?
Leadership
2
2021
358
0.580
Why?
Treatment Adherence and Compliance
1
2017
22
0.560
Why?
Career Choice
1
2018
211
0.520
Why?
Resilience, Psychological
1
2018
118
0.510
Why?
Deglutition Disorders
1
2017
129
0.500
Why?
Injections
1
2015
174
0.470
Why?
Education, Medical
1
2018
246
0.470
Why?
Simulation Training
1
2015
80
0.450
Why?
Voice
2
2017
10
0.430
Why?
Education, Medical, Undergraduate
1
2016
174
0.430
Why?
Occupational Diseases
2
2006
142
0.390
Why?
Patient Care Team
1
2017
607
0.390
Why?
Vocal Cords
4
2006
27
0.390
Why?
Burnout, Professional
1
2018
399
0.380
Why?
Carcinoma, Hepatocellular
2
2020
267
0.370
Why?
Hepatitis C
2
2020
235
0.360
Why?
Education, Medical, Graduate
3
2019
438
0.320
Why?
Liver Neoplasms
2
2020
637
0.300
Why?
Inhibin-beta Subunits
1
2006
5
0.260
Why?
Activins
1
2006
27
0.260
Why?
Schistosomiasis
1
2006
47
0.250
Why?
Job Application
2
2015
13
0.230
Why?
Insulin-Like Growth Factor I
1
2006
308
0.220
Why?
Postpoliomyelitis Syndrome
1
2001
4
0.190
Why?
Humans
25
2023
129706
0.190
Why?
Glypicans
1
2020
9
0.180
Why?
Dipeptidyl Peptidase 4
1
2020
13
0.180
Why?
Neurofibromatosis 2
2
1998
4
0.170
Why?
Equipment Design
2
2015
527
0.170
Why?
Voice Quality
2
2014
16
0.160
Why?
Pilot Projects
2
2019
1567
0.160
Why?
Disability Evaluation
1
2000
291
0.150
Why?
Otolaryngologists
1
2017
10
0.140
Why?
Speech-Language Pathology
1
2017
19
0.140
Why?
United States
4
2019
14078
0.140
Why?
Organizational Culture
1
2018
138
0.130
Why?
Educational Status
1
2019
466
0.130
Why?
Interviews as Topic
1
2019
698
0.130
Why?
Competitive Behavior
1
2015
42
0.120
Why?
Psychoses, Substance-Induced
2
2007
14
0.120
Why?
Dysphonia
1
2014
12
0.120
Why?
Speech Acoustics
1
2014
11
0.120
Why?
Faculty, Medical
1
2018
263
0.120
Why?
Clinical Clerkship
1
2016
89
0.120
Why?
Cell Division
1
1996
802
0.110
Why?
Female
12
2021
68562
0.110
Why?
Egypt
2
2020
10
0.110
Why?
Program Evaluation
1
2018
880
0.110
Why?
Electromyography
2
2007
380
0.110
Why?
School Admission Criteria
1
2013
23
0.110
Why?
Clinical Competence
2
2019
1026
0.110
Why?
Educational Measurement
1
2016
259
0.110
Why?
Attitude
1
2015
248
0.100
Why?
Correspondence as Topic
1
2012
14
0.100
Why?
Societies, Medical
1
2016
763
0.090
Why?
Students, Medical
1
2016
307
0.090
Why?
Writing
1
2012
92
0.090
Why?
Male
12
2018
63544
0.090
Why?
Surgeons
1
2015
279
0.090
Why?
Nasal Decongestants
2
2007
8
0.080
Why?
Histamine H1 Antagonists
2
2007
30
0.080
Why?
Anti-Ulcer Agents
2
2007
15
0.080
Why?
Biomedical Research
1
2015
656
0.080
Why?
Vocal Cord Paralysis
2
2005
29
0.070
Why?
Music
1
2006
40
0.060
Why?
Analgesics
1
2007
174
0.060
Why?
Movement Disorders
1
2005
53
0.060
Why?
Vagus Nerve Diseases
1
2002
1
0.050
Why?
Glucocorticoids
1
2007
573
0.050
Why?
Severity of Illness Index
3
2014
2783
0.050
Why?
Cough
1
2002
118
0.050
Why?
Laryngeal Diseases
1
2001
26
0.050
Why?
Amyloidosis
1
2001
39
0.050
Why?
Myasthenia Gravis
23
NaN
Why?
Cicatrix
1
2001
58
0.040
Why?
alpha-Fetoproteins
1
2020
39
0.040
Why?
Parkinson Disease
1
2005
408
0.040
Why?
Middle Aged
6
2006
31103
0.040
Why?
Gastroesophageal Reflux
1
2002
242
0.040
Why?
Audiometry, Pure-Tone
2
1998
26
0.040
Why?
Adult
5
2006
35596
0.040
Why?
Drug Prescriptions
1
2001
254
0.040
Why?
Hepacivirus
1
2020
237
0.040
Why?
Ear Neoplasms
1
1998
8
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2001
259
0.040
Why?
Acute Disease
1
2001
984
0.040
Why?
Neurilemmoma
1
1998
23
0.040
Why?
Adipose Tissue
1
2001
588
0.030
Why?
Stroke
1
2005
1111
0.030
Why?
Spinal Neoplasms
1
1996
29
0.030
Why?
Reproducibility of Results
2
2014
3054
0.030
Why?
Speech Production Measurement
1
2014
12
0.030
Why?
Hearing Loss
1
1998
208
0.030
Why?
Follow-Up Studies
3
2001
4939
0.030
Why?
Judgment
1
2014
57
0.030
Why?
Area Under Curve
1
2014
287
0.030
Why?
Biomarkers, Tumor
1
2020
1171
0.030
Why?
Signal Processing, Computer-Assisted
1
2014
143
0.030
Why?
Observer Variation
1
2014
321
0.030
Why?
Speech Perception
1
2014
81
0.030
Why?
ROC Curve
1
2014
503
0.030
Why?
Prospective Studies
2
2014
7131
0.020
Why?
Aged
3
2005
22113
0.020
Why?
Biomarkers
1
2020
3893
0.020
Why?
Predictive Value of Tests
1
2014
1981
0.020
Why?
Patient Selection
1
2012
685
0.020
Why?
Age Factors
1
1996
3145
0.020
Why?
Magnetic Resonance Imaging
2
1998
3351
0.020
Why?
Case-Control Studies
1
2014
3363
0.020
Why?
Algorithms
1
2014
1632
0.020
Why?
Age Distribution
1
2005
380
0.010
Why?
Sex Distribution
1
2005
361
0.010
Why?
Risk Assessment
2
2005
3297
0.010
Why?
Brain
1
1996
2596
0.010
Why?
Cross-Sectional Studies
1
2015
5050
0.010
Why?
Surveys and Questionnaires
1
2015
5396
0.010
Why?
Hoarseness
1
2001
4
0.010
Why?
Laryngeal Muscles
6
NaN
Why?
Pyridostigmine Bromide
5
NaN
Why?
Otorhinolaryngologic Surgical Procedures
1
2001
33
0.010
Why?
Cholinesterase Inhibitors
28
NaN
Why?
Injections, Intramuscular
1
2001
131
0.010
Why?
Biopsy, Needle
1
2001
192
0.010
Why?
Medical History Taking
1
2001
122
0.010
Why?
Drug Therapy
1
2001
77
0.010
Why?
Transplantation, Autologous
1
2001
214
0.010
Why?
Steroids
1
2001
148
0.010
Why?
Drug Utilization
1
2001
170
0.010
Why?
Incidence
1
2005
2658
0.010
Why?
Speech Reception Threshold Test
1
1998
1
0.010
Why?
Reflex, Vestibulo-Ocular
1
1998
10
0.010
Why?
Retrospective Studies
2
2001
14669
0.010
Why?
Diagnosis, Differential
1
2002
1442
0.010
Why?
Anti-Inflammatory Agents
1
2001
471
0.010
Why?
Evoked Potentials, Auditory, Brain Stem
1
1998
51
0.010
Why?
Prognosis
1
2005
3801
0.010
Why?
Adolescent
1
1996
20355
0.010
Why?
Chronic Disease
1
2002
1721
0.010
Why?
Child
1
1996
20963
0.010
Why?
Aged, 80 and over
1
2005
7074
0.010
Why?
Practice Patterns, Physicians'
1
2001
1287
0.010
Why?
Risk Factors
1
2001
9832
0.000
Why?
Treatment Outcome
1
2001
10299
0.000
Why?
Abaza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)